Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Pecoraro

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
BJU International|February 26, 2024
Psychosocial outcomes in the Yorkshire Kidney Screening Trial: moving the needle toward targeted screening for renal cell carcinomaRiccardo Campi, Alessio Pecoraro, Sergio Serni
European Urology|July 11, 2022
Re: 'Case of the Month' from the Specialist Centre for Kidney Cancer, Royal Free London Hospital, UK: <sup>99m</sup>Tc-sestamibi SPECT-CT to Differentiate Renal Cell Carcinoma from Benign Oncocytoma: The promise of value-oriented, cost-effective, shared decision-making for patients with localized renal masses: new imaging tools for a new diagnostic work-upRiccardo Campi, Alessio Pecoraro, Sergio Serni
European Urology Oncology|July 12, 2023
Robotic Versus Open Partial Nephrectomy: From the "Shadows" of Randomized Controlled Trials to the "Reality" of Value-based Care for Patients with Localized Renal MassesRiccardo Campi, Alessio Pecoraro, Sergio Serni, et al.
The Journal of Urology|July 7, 2023
Editorial CommentRiccardo Campi, Alessio Pecoraro, Lorenzo Antonuzzo, et al.
European Urology Open Science|February 28, 2022
Re-envisioning Patient Education and Public Awareness of Urological Cancers at the Time of the COVID-19 PandemicAlessio Pecoraro, Eduard Roussel, Sergio Serni, et al.
European Urology|October 23, 2024
Re: [<sup>89</sup>Zr]Zr-Girentuximab for PET-CT Imaging of Clear-cell Renal Cell Carcinoma: A Prospective, Open-label, Multicentre, Phase 3 TrialRiccardo Campi, Alessio Pecoraro, Salvatore Granata, et al.
European Urology Focus|July 7, 2022
Re: Julia Dagnæs-Hansen, Gitte Hjartbro Kristensen, Hein V. Stroomberg, Søren Schwartz Sørensen, Martin Andreas Røder. Surgical Approaches and Outcomes in Living Donor Nephrectomy: A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.03.021Alessio Pecoraro, Vincenzo Li Marzi, Sergio Serni, et al.
Minerva Urology and Nephrology|May 24, 2023
Morbidity and mortality of metastasectomy for renal cell carcinoma: is centralization of care the way forward?Michele Marchioni, Daniele Amparore, Alessio Pecoraro, et al.
Minerva Urology and Nephrology|January 11, 2023
Comment on: "Surgeon preimplantation macroscopic graft appraisal improves risk stratification of deceased kidney donors: a prospective study"Alberto Piana, Alberto Breda, Alessio Pecoraro, et al.
Minerva Urology and Nephrology|March 1, 2024
Metastatic de-novo renal cell carcinoma in the era of immune combinations: what can we learn from real-world data?Giulio Francolini, Laura Marandino, Chiara Ciccarese, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
BJU International|February 26, 2024
Psychosocial outcomes in the Yorkshire Kidney Screening Trial: moving the needle toward targeted screening for renal cell carcinomaRiccardo Campi, Alessio Pecoraro, Sergio Serni
European Urology|July 11, 2022
Re: 'Case of the Month' from the Specialist Centre for Kidney Cancer, Royal Free London Hospital, UK: <sup>99m</sup>Tc-sestamibi SPECT-CT to Differentiate Renal Cell Carcinoma from Benign Oncocytoma: The promise of value-oriented, cost-effective, shared decision-making for patients with localized renal masses: new imaging tools for a new diagnostic work-upRiccardo Campi, Alessio Pecoraro, Sergio Serni
European Urology Oncology|July 12, 2023
Robotic Versus Open Partial Nephrectomy: From the "Shadows" of Randomized Controlled Trials to the "Reality" of Value-based Care for Patients with Localized Renal MassesRiccardo Campi, Alessio Pecoraro, Sergio Serni, et al.
The Journal of Urology|July 7, 2023
Editorial CommentRiccardo Campi, Alessio Pecoraro, Lorenzo Antonuzzo, et al.
European Urology Open Science|February 28, 2022
Re-envisioning Patient Education and Public Awareness of Urological Cancers at the Time of the COVID-19 PandemicAlessio Pecoraro, Eduard Roussel, Sergio Serni, et al.
European Urology|October 23, 2024
Re: [<sup>89</sup>Zr]Zr-Girentuximab for PET-CT Imaging of Clear-cell Renal Cell Carcinoma: A Prospective, Open-label, Multicentre, Phase 3 TrialRiccardo Campi, Alessio Pecoraro, Salvatore Granata, et al.
European Urology Focus|July 7, 2022
Re: Julia Dagnæs-Hansen, Gitte Hjartbro Kristensen, Hein V. Stroomberg, Søren Schwartz Sørensen, Martin Andreas Røder. Surgical Approaches and Outcomes in Living Donor Nephrectomy: A Systematic Review and Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.03.021Alessio Pecoraro, Vincenzo Li Marzi, Sergio Serni, et al.
Minerva Urology and Nephrology|May 24, 2023
Morbidity and mortality of metastasectomy for renal cell carcinoma: is centralization of care the way forward?Michele Marchioni, Daniele Amparore, Alessio Pecoraro, et al.
Minerva Urology and Nephrology|January 11, 2023
Comment on: "Surgeon preimplantation macroscopic graft appraisal improves risk stratification of deceased kidney donors: a prospective study"Alberto Piana, Alberto Breda, Alessio Pecoraro, et al.
Minerva Urology and Nephrology|March 1, 2024
Metastatic de-novo renal cell carcinoma in the era of immune combinations: what can we learn from real-world data?Giulio Francolini, Laura Marandino, Chiara Ciccarese, et al.
Pageof 10